Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page
- Check6 days agoChange DetectedA minor revision update indicates version v3.3.2 was published; no changes to core study content, eligibility, outcomes, or locations are evident in the visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Tainan, Taiwan, 704 to the Locations section. Replaced the listing 'Tainan City, Taiwan, 704' with 'Tainan, Taiwan, 704' to reflect corrected locality naming.SummaryDifference0.4%

- Check34 days agoChange DetectedNo substantive content changes detected on the Study Details page; updates appear to be UI/formatting adjustments without changes to core sections such as eligibility criteria or outcome measures — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center (high importance). - Updated version to v3.2.0; removed v3.1.0 reference.SummaryDifference4%

- Check70 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.